COMMUNIQUÉS West-GlobeNewswire

Arvinas Appoints Jared Freedberg as General Counsel

16/01/2024 - 23:01

Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company [...]

New ReNu® Data from Organogenesis Highlighted at ICRS 2019 World Congress

05/10/2019 - 15:00

CANTON, Mass. and VANCOUVER, British Columbia, Oct. 05, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and [...]

Pure Sunfarms, la coentreprise d'Emerald Health Therapeutics, commence à expédier ses produits de marque à base de cannabis à un grossiste de la province de la Colombie-Britannique

05/10/2019 - 00:38

VANCOUVER, Colombie-Britannique, 04 oct. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF), a annoncé aujourd'hui que sa coentreprise détenue à 50 % pour la production [...]

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/10/2019 - 23:30

CRESTWOOD, Ky. and WALTHAM Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Aeterna Zentaris Announces Appointment of New President and Chief Executive Officer

04/10/2019 - 22:59

CHARLESTON, S.C., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today announced the appointment of Klaus Paulini as President and Chief Executive Officer of the Company, effective [...]

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/10/2019 - 22:30

BURLINGTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to 13 new employees consisting of an aggregate of 80,550 stock options and 13,425 [...]

Natus Medical to Hold 2019 Third Quarter Financial Results Conference all on October 24th

04/10/2019 - 22:15

PLEASANTON, Calif., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of [...]

Avadel Announces Resignation of Kevin Kotler from Board of Directors

04/10/2019 - 22:05

DUBLIN, Ireland, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, a once-nightly formulation of sodium oxybate, for narcolepsy, today announced that [...]

HEXO Corp Announces Resignation of Chief Financial Officer

04/10/2019 - 22:05

GATINEAU, Quebec, Oct. 04, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) today announced that the company’s Chief Financial Officer, Michael Monahan, has made the decision to resign [...]

HEXO Corp annonce la démission de son chef de la direction financière

04/10/2019 - 22:05

GATINEAU, Québec, 04 oct. 2019 (GLOBE NEWSWIRE) -- HEXO Corp, (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE : HEXO) a annoncé aujourd'hui que le chef de la direction financière de la Société, Michael Monahan, a pris [...]

Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans

04/10/2019 - 21:28

VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) announces that it has reached agreement with third parties as well as certain [...]

Dabir Surfaces Inc. Announces Launch of the Dabir Patient Care System

04/10/2019 - 19:25

CHICAGO, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Dabir Surfaces, Inc., a subsidiary of Methode Electronics, Inc. (NYSE: MEI), focused on improving patient outcomes through the design and manufacture of an innovative solution [...]

1.7 Million Dollars Grant Towards Development of Theratechnologies’ Targeted Oncology

04/10/2019 - 19:00

MONTREAL, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Canadian Cancer Society and the Government of Quebec, through the Consortium Québécois sur [...]

Octroi de 1,7 million de dollars en vue du développement de la plateforme ciblée en oncologie de Theratechnologies

04/10/2019 - 19:00

MONTREAL, 04 oct. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que la Société Canadienne du cancer (SCC) et le gouvernement du Québec, par le biais du Consortium [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 30 Septembre 2019

04/10/2019 - 18:00

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 04 oct. 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]

Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2019

04/10/2019 - 18:00

Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- [...]

DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy

04/10/2019 - 17:45

Montrouge, France, October 4, 2019 DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy If approved, Viaskin Peanut would be the first and only epicutaneous [...]

DBV Technologies annonce l'acceptation par la FDA du dépôt de sa demande de sa Licence Biologique pour Viaskin Peanut, un traitement de l'allergie aux arachides

04/10/2019 - 17:45

Montrouge, France, le 4 octobre (17 h 30 CEST) 2019 DBV Technologies annonce l'acceptation par la FDA du dépôt de sa demande de sa Licence Biologique pour Viaskin Peanut, un traitement de l'allergie aux arachides Si [...]

Pixium Vision provides clarification on Omnes Capital shareholding, unchanged since end 2017

04/10/2019 - 16:17

Paris, 4 October 2019 – 16:00 CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, [...]